S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
LON:POLX

Polarean Imaging (POLX) Share Forecast, Price & News

GBX 10.10
+0.70 (+7.45%)
(As of 09/29/2023 ET)
Compare
Today's Range
9.40
10.39
50-Day Range
9.38
22.50
52-Week Range
9
84.20
Volume
1.77 million shs
Average Volume
723,296 shs
Market Capitalization
£21.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

POLX stock logo

About Polarean Imaging (LON:POLX) Stock

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.

POLX Price History

POLX Stock News Headlines

Polarean Imaging appoints new non-executive director
6.5 Million Americans Are DESPERATE for This New Drug from One Tiny Company
Decades of pent-up demand for this "first-ever" treatment could give you WINDFALL PROFITS... Click here to learn more >>>
WARNING: Seven millionaires to trigger sudden market panic?
The next major selloff could be just days away…And seven powerful (yet completely unknown) insiders will be behind it all – and help corporate executives make a killing as it plays out. Here’s the full story.
Polarean Imaging PLC surges as XENOVIEW gets FDA green light
Polarean Imaging surges as XENOVIEW gets FDA green light
Polarean Imaging plc (POLX.L)
Polarean Imaging says US regulator accepts updated submission
See More Headlines
Receive POLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
28
Year Founded
N/A

Profitability

Net Income
£-14,340,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.03 million
Cash Flow
GBX 2.08 per share
Book Value
GBX 6 per share

Miscellaneous

Free Float
N/A
Market Cap
£22.07 million
Optionable
Not Optionable
Beta
0.76
The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Kenneth Paul West (Age 66)
    Chairman
    Comp: $38.25k
  • Dr. Bastiaan Driehuys Ph.D. (Age 54)
    Founder, CTO & Director
    Comp: $43.25k
  • Mr. Charles Fremont Osborne Jr. (Age 57)
    CFO & Director
    Comp: $315.42k
  • Mr. Clairis Richard Hullihen (Age 70)
    Exec. Officer
    Comp: $348.52k
  • Dr. Christopher Richard Von Jako Ph.D. (Age 53)
    CEO & Director
  • Mr. Neil Wadehra (Age 43)
    VP of Operations
  • Mr. Alex Dusek (Age 56)
    Chief Commercial Officer
  • Mr. Stephen Austin
    Company Sec.













POLX Stock - Frequently Asked Questions

How have POLX shares performed in 2023?

Polarean Imaging's stock was trading at GBX 56 at the beginning of 2023. Since then, POLX stock has decreased by 81.7% and is now trading at GBX 10.23.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Polarean Imaging own?
What is Polarean Imaging's stock symbol?

Polarean Imaging trades on the London Stock Exchange (LON) under the ticker symbol "POLX."

How do I buy shares of Polarean Imaging?

Shares of POLX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Polarean Imaging's stock price today?

One share of POLX stock can currently be purchased for approximately GBX 10.23.

How much money does Polarean Imaging make?

Polarean Imaging (LON:POLX) has a market capitalization of £22.07 million and generates £1.03 million in revenue each year. The company earns £-14,340,000.00 in net income (profit) each year or GBX (0.05) on an earnings per share basis.

How can I contact Polarean Imaging?

Polarean Imaging's mailing address is 2500 Meridian Parkway, Suite 175, Durham, NC 27713, United States. The official website for the company is www.polarean.com. The company can be reached via phone at 919 206 7900.

This page (LON:POLX) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -